Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Belgium

 

Cerba to buy JS Bio Selas

Franco-Belgian lab chain Cerba European Lab, where PAI has a majority stake, has carried out a bond issue to buy French regional lab chain JS Bio Selas. Meanwhile it has denied rumours that its Luxembourgoise lab Laboratoires Ketterthill is for sale. We look at the price it has paid and at Cerba’s European strategy.

Report: Dentistry in Europe

Web-empowered, patient choice, the retreat of state payors, internationalization - what is happening in dentistry will happen in other healthcare service sectors soon. So it is a sector that is worth watching closely. In this, the first part of a 2 part report, we look at how dentistry markets in Europe are changing, look at business models and track consolidation, naming the major players country-by-country. How is the market set to change?

Ribon sets up new healthcare fund

Denis Ribon,former global head of healthcare at 3i, has set up a new business Archimed to invest in healthcare services, medtech and pharma in Western Europe.

Diagnostics: A Decade of Potential: Presentation, Jerome Thill, Director General, Cerba

Who better than Cerba to look at the opportunities now opening up? As well as routine labs, the big Franco-Benelux player also runs one of the largest European specialty and central lab operations. Jérôme looks at how Cerba is building a brand in routine testing, embracing innovation tests in its reference operation and developing next generation biomarkers in its central lab. Presented at the Healthcare Europa Annual Conference 2014, The Return of the Bull Market.

German healthcare tourism streaks ahead

Germany treated 224,000 foreign patients in 2012. But how many flew to Germany for treatment, as opposed to being sick holiday-makers? How do the numbers compare to the UK and other European countries? And how many are treated in the private sector? One thing is sure: Russia is Germany’s largest market today.

Find Us